PH30665A - Aminosulfonyl urea acat inhibitors - Google Patents
Aminosulfonyl urea acat inhibitorsInfo
- Publication number
- PH30665A PH30665A PH43413A PH43413A PH30665A PH 30665 A PH30665 A PH 30665A PH 43413 A PH43413 A PH 43413A PH 43413 A PH43413 A PH 43413A PH 30665 A PH30665 A PH 30665A
- Authority
- PH
- Philippines
- Prior art keywords
- acat inhibitors
- aminosulfonyl
- compounds
- aminosulfonyl urea
- urea acat
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
- C07D211/96—Sulfur atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C307/00—Amides of sulfuric acids, i.e. compounds having singly-bound oxygen atoms of sulfate groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C307/04—Diamides of sulfuric acids
- C07C307/06—Diamides of sulfuric acids having nitrogen atoms of the sulfamide groups bound to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C307/00—Amides of sulfuric acids, i.e. compounds having singly-bound oxygen atoms of sulfate groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C307/04—Diamides of sulfuric acids
- C07C307/08—Diamides of sulfuric acids having nitrogen atoms of the sulfamide groups bound to carbon atoms of rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C307/00—Amides of sulfuric acids, i.e. compounds having singly-bound oxygen atoms of sulfate groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C307/04—Diamides of sulfuric acids
- C07C307/10—Diamides of sulfuric acids having nitrogen atoms of the sulfamide groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/14—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Furan Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US61028790A | 1990-11-07 | 1990-11-07 | |
US07/747,040 US5214206A (en) | 1990-11-07 | 1991-08-19 | Aminosulfonyl urea acat inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
PH30665A true PH30665A (en) | 1997-09-16 |
Family
ID=27086230
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PH43413A PH30665A (en) | 1990-11-07 | 1991-11-06 | Aminosulfonyl urea acat inhibitors |
Country Status (16)
Country | Link |
---|---|
US (2) | US5214206A (ja) |
EP (1) | EP0556322B1 (ja) |
JP (2) | JP3256541B2 (ja) |
AT (1) | ATE139226T1 (ja) |
AU (1) | AU657928B2 (ja) |
CA (1) | CA2094806C (ja) |
DE (1) | DE69120287T2 (ja) |
DK (1) | DK0556322T3 (ja) |
ES (1) | ES2088128T3 (ja) |
GR (1) | GR3020355T3 (ja) |
IE (1) | IE75379B1 (ja) |
MX (1) | MX9101958A (ja) |
NZ (1) | NZ240481A (ja) |
PH (1) | PH30665A (ja) |
PT (1) | PT99435B (ja) |
WO (1) | WO1992008694A1 (ja) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2145743T3 (es) * | 1990-12-28 | 2000-07-16 | Teijin Ltd | Compuesto de anillo condensado benzoxa, su produccion y composicion farmaceutica que lo contiene. |
US5576335A (en) * | 1994-02-01 | 1996-11-19 | Nisshin Flour Milling Co., Ltd. | Urea derivatives and their use as ACAT inhibitors |
US5491170A (en) * | 1994-12-19 | 1996-02-13 | Warner-Lambert Company | β-carboxy sulfonamide ACAT inhibitors |
US6103733A (en) * | 1998-09-09 | 2000-08-15 | Bachmann; Kenneth A. | Method for increasing HDL cholesterol levels using heteroaromatic phenylmethanes |
CA2369967A1 (en) * | 2001-02-12 | 2002-08-12 | Joseph Anthony Cornicelli | Methods of treating nuclear factor-kappa b mediated diseases and disorders |
EP1281399A3 (en) * | 2001-08-01 | 2004-02-11 | Warner-Lambert Company | Dual inhibitors of wax ester and cholesteryl ester synthesis for inhibiting sebum production |
CA2997471C (en) * | 2010-11-16 | 2020-12-01 | Texas Heart Institute | Agonists that enhance binding of integrin-expressing cells to integrin receptors |
CN103288749A (zh) * | 2013-03-04 | 2013-09-11 | 盐城工学院 | 可作除草剂的氨基磺酰脲类化合物 |
EP3598983A1 (en) * | 2014-10-03 | 2020-01-29 | Synaffix B.V. | Sulfamide linker, conjugates thereof, and methods of preparation |
US10538487B2 (en) | 2015-02-16 | 2020-01-21 | The University Of Queensland | Sulfonylureas and related compounds and use of same |
BR112018016671A2 (pt) * | 2016-02-16 | 2018-12-26 | The University Of Queensland | sulfonilureias e compostos relacionados e uso do mesmo |
HRP20220195T1 (hr) | 2017-07-07 | 2022-04-15 | Inflazome Limited | Novi spojevi sulfonamid karboksamida |
GB201721185D0 (en) * | 2017-12-18 | 2018-01-31 | Nodthera Ltd | Sulphonyl urea derivatives |
CR20210139A (es) * | 2018-08-15 | 2021-06-24 | Inflazome Ltd | Compuestos de sulfonamidaurea novedosos |
US12054461B2 (en) | 2019-06-12 | 2024-08-06 | NodThera Limited | Sulfonylurea derivatives and uses thereof |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2312404A (en) * | 1939-11-22 | 1943-03-02 | Haack Erich | Method of preparing n-sulphonylureas |
CH396872A (de) * | 1959-08-13 | 1965-08-15 | Ciba Geigy | Verfahren zur Herstellung neuer Harnstoffe |
US3242174A (en) * | 1962-02-06 | 1966-03-22 | Pfizer & Co C | 1-(tertiary aminosulfonyl)-3-(hydrocarbon) ureas |
GB990860A (en) * | 1962-02-08 | 1965-05-05 | Pfizer & Co C | N,n-disubstituted sulfamylureas and compositions thereof |
US3245982A (en) * | 1962-03-27 | 1966-04-12 | Pfizer & Co C | Sulfamylsemicarbazides |
DE1518541A1 (de) * | 1965-03-16 | 1969-09-11 | Boehringer Mannheim Gmbh | Verfahren zur Herstellung von Sulfonylharnstoffen und Sulfonylsemicarbaziden |
CH649081A5 (de) * | 1982-01-12 | 1985-04-30 | Ciba Geigy Ag | Triaza-verbindungen. |
-
1991
- 1991-08-19 US US07/747,040 patent/US5214206A/en not_active Expired - Lifetime
- 1991-11-05 DE DE69120287T patent/DE69120287T2/de not_active Expired - Fee Related
- 1991-11-05 CA CA002094806A patent/CA2094806C/en not_active Expired - Fee Related
- 1991-11-05 AT AT92900981T patent/ATE139226T1/de not_active IP Right Cessation
- 1991-11-05 JP JP50093292A patent/JP3256541B2/ja not_active Expired - Fee Related
- 1991-11-05 EP EP92900981A patent/EP0556322B1/en not_active Expired - Lifetime
- 1991-11-05 NZ NZ240481A patent/NZ240481A/xx not_active IP Right Cessation
- 1991-11-05 AU AU89597/91A patent/AU657928B2/en not_active Ceased
- 1991-11-05 ES ES92900981T patent/ES2088128T3/es not_active Expired - Lifetime
- 1991-11-05 DK DK92900981.9T patent/DK0556322T3/da active
- 1991-11-05 WO PCT/US1991/008223 patent/WO1992008694A1/en active IP Right Grant
- 1991-11-06 PT PT99435A patent/PT99435B/pt not_active IP Right Cessation
- 1991-11-06 PH PH43413A patent/PH30665A/en unknown
- 1991-11-06 IE IE387491A patent/IE75379B1/en not_active IP Right Cessation
- 1991-11-06 MX MX9101958A patent/MX9101958A/es not_active IP Right Cessation
-
1993
- 1993-02-19 US US08/019,519 patent/US5288757A/en not_active Expired - Lifetime
-
1996
- 1996-06-27 GR GR960401724T patent/GR3020355T3/el unknown
-
2000
- 2000-06-14 JP JP2000177740A patent/JP2001026574A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
IE913874A1 (en) | 1992-05-20 |
GR3020355T3 (en) | 1996-09-30 |
JPH06501707A (ja) | 1994-02-24 |
NZ240481A (en) | 1994-06-27 |
IE75379B1 (en) | 1997-09-10 |
DE69120287D1 (en) | 1996-07-18 |
DK0556322T3 (da) | 1996-10-14 |
PT99435B (pt) | 1999-04-30 |
EP0556322B1 (en) | 1996-06-12 |
DE69120287T2 (de) | 1996-10-10 |
JP3256541B2 (ja) | 2002-02-12 |
US5288757A (en) | 1994-02-22 |
CA2094806C (en) | 2004-11-02 |
AU8959791A (en) | 1992-06-11 |
US5214206A (en) | 1993-05-25 |
CA2094806A1 (en) | 1992-05-08 |
ES2088128T3 (es) | 1996-08-01 |
PT99435A (pt) | 1992-12-31 |
JP2001026574A (ja) | 2001-01-30 |
ATE139226T1 (de) | 1996-06-15 |
EP0556322A1 (en) | 1993-08-25 |
WO1992008694A1 (en) | 1992-05-29 |
MX9101958A (es) | 1992-07-08 |
AU657928B2 (en) | 1995-03-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69726577D1 (en) | Kristallin form i von clarithromycin | |
TR199901172T2 (xx) | Yeni ikame edilmi� pirazol t�revleri. | |
FI962154A (fi) | Koostumus terapeuttisten tuotteiden in vivo valmistusta varten | |
MX9704030A (es) | 1,1-dioxidos de 2-heterocicliloxi y tiometil-1,2,5-tiadiazolidin-3-ona y composiciones y metodo de uso de los mismos. | |
IL125282A (en) | Substituted imidazole compounds, process for their preparation, pharmaceutical compositions containing them and use thereof in the preparation of medicaments for treating cytokine mediated diseases | |
MY129189A (en) | Prostaglandin agonists and their use to treat bone disorders | |
NO971889D0 (no) | Forbindelser og sammensetninger for levering av aktive midler | |
SE9704546D0 (sv) | Novel compounds | |
ATE185548T1 (de) | Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress | |
DK0725779T3 (da) | Hidtil ukendte (R)-5-Carbamoyl-8-fluor-3-N,N-disubstitueret-amino-3,4-dihydro-2H-1-benzopyraner | |
EE9900539A (et) | Uued ühendid | |
DE69905170D1 (en) | Thiazolopyrimidinderivate | |
DE69120287D1 (en) | Aminosulfonylharnstoff-acat-inhibitoren | |
BG103399A (en) | New heterocycle-substituted benzamides and their application for the treatment of diseases | |
MX9702170A (es) | Uso de inhibidores de la aromatasa para la produccion de un agente farmaceutico para el tratamiento de una deficiencia de androgeno relativa en los hombres. | |
HRP20020330B1 (ja) | ||
AU5186799A (en) | Peptides of il-2 and derivatives thereof and their use as therapeutic agents | |
EP0793660A4 (en) | 2-SUBSTITUTED 1,2,5-THIADIAZOLIDIN-3-ON-1,1-DIOXIDES, COMPOSITION AND THEIR USE | |
SE9802937D0 (sv) | Novel compounds | |
MX9403088A (es) | Composiciones farmaceuticas que contienen deriva- dos de indol y metodos de uso. | |
AU6415994A (en) | Substituted caprolactams and derivatives thereof useful for treatment of hiv disease | |
RU94041028A (ru) | Применение производных мелатонина для лечения десинхронизационных нарушений, фармацевтическая композиция | |
MX9604762A (es) | Nuevas sulfonamidas y procedimiento para su preparacion. | |
IL106237A0 (en) | Piperidyl amides,sulfonamides and sulfoxamides as inhibitors of cholesterol biosynthesis | |
DK0720597T3 (da) | Triarylethylenderivater til terapeutisk anvendelse |